Reaction: Meloxicam to 1 product

Reaction
Meloxicam
DB00814
    5'-hydroxymethyl meloxicam
    DBMET00755
    Reaction type
    Not Available
    Direction
    Not Available
    Major circulating metabolite?
    No
    Spontaneous?
    No
    Activity
    unknown
    References
    1. Prasad GS, Srisailam K, Sashidhar RB: Metabolic inhibition of meloxicam by specific CYP2C9 inhibitors in Cunninghamella blakesleeana NCIM 687: in silico and in vitro studies. Springerplus. 2016 Feb 24;5:166. doi: 10.1186/s40064-016-1794-4. eCollection 2016. [Article]
    2. FDA approved products: Mobic (meloxicam) oral tablets [Link]
    Comments
    The bacteria Cunninghamella blakesleeana is reported to be involved in the biotransformation of meloxicam.
    Enzymes
    Not Available